SummarY
Initial studies of the kinetics of unconjugated bilirubin metabolism in man involved the analysis, in terms of two exponential functions, of the plasma disappearance curves of unlabelled bilirubin after the intravenous injection of a loading dose of bilirubin in normal subjects and patients with mild congenital hyperbilirubinaemia (Billing, Williams & Richards, 1964) . At the same time, tracer amounts of radio-labelled unconjugated bilirubin were used in similar studies in patients with the Crigler-Najjar syndrome, the 'curves' obtained being analysed in terms of a single exponential (Schmid & Hammaker, 1963 ; Billing, Gray, Kukczycka, Manfield & Nicholson, 1964) . Subsequently, the plasma disappearance curves of labelled unconjugated bilirubin were defined in normal subjects and in patients with mild unconjugated hyperbilirubinaemia in terms of two (Barrett, Berk, Menken & Berlin, 1968) and later three exponential functions (Berk, Howe, Bloomer & Berlin, 1969; Berk, Bloomer, Howe & Berlin, 1970) . Analysis of the plasma disappearance curves, using three exponentials, enabled the parameters of a simple threepool model of unconjugated bilirubin metabolism to be determined (Berk et al., 1969) . Kinetic studies of unconjugated bilirubin metabolism using this three-pool model have been conducted in normal subjects (Berk e f al., 1969) and in patients with Gilbert's (Berk et al., 1970) and Crigler-Najjar syndromes (Bloomer, Berk, Howe & Berlin, 1971) . Comparable studies of the kinetics of unconjugated bilirubin metabolism in chronic liver disease have not been carried out. The only available studies of unconjugated bilirubin metabolism in cirrhosis have involved the definition of plasma bilirubin disappearance curves in terms of only two exponential functions (Barrett et al., 1968; Schmidt, Eisenburg & Stich, 1971 ) and the study of patients with conjugated hyperbilirubinaemia (Schmidt et al., 1971 ; Bloomer, Berk & Howe, 1974 ), a factor known to limit the precision with which the plasma labelled unconjugated bilirubin disappearance curves can be defined (Owens, 1975) .
This paper reports studies of the kinetics of 14C-labelled unconjugated bilirubin metabolism in a group of normal subjects and a group of patients with compensated cirrhosis who did not have an appreciable degree of conjugated hyperbilirubinaemia. The plasma disappearance curves of unconjugated [ 4C]bilirubin have been defined and analysed in terms of three exponentials and the three-pool model of bilirubin metabolism proposed by Berk et al. (1969) . The data obtained for the normal subjects are the only available data which are comparable with those obtained for normal subjects by Berk et al. (1969) and are in broad agreement with the original findings of these authors. The results in the cirrhotic subjects constitute the first comprehensive study of unconjugated bilirubin metabolism in patients with this disease.
Materials, subjects and methods
Preparation of unconjugated [ l 4C]bilirubin

Unconjugated [14C]bilirubin was prepared biosynthetically from 5-[4-14C]aminolaevulinic
acid in dogs with bile fistulae by a modification of the method described by Barrett, Mullins & Berlin (1966) . The modifications were as follows.
(a) 1 mCi of 5-[4-14C]aminolaevulinic acid was injected into each dog. (b) The dog's enterohepatic circulation was preserved until bile was to be collected. This was achieved by cannulating the common bile duct and connecting the cannula subcutaneously to a second cannula introduced via a pursestring suture into the duodenum. The connection between the cannulae could be exteriorized through a small superficial incision and undone for the purpose of collecting bile. (c) Pancreozymin (Boots Pure Drug Co., Nottingham, U.K.) was injected (2 Crick-Harper-Raper units/kg body weight) intravenously into the dogs during bile collection in order to empty the gall-bladder.
(d) Columns of anhydrous sodium sulphate were used instead of alumina to purify the bilirubin, as recommended by Fog (1964) . Although these modifications were designed to increase the specific radioactivity and yield of unconjugated [14C]bilirubin, only approximately 5% of the injected radioactivity was recovered as pure labelled bilirubin.
Purity of unconjugated [l 4c]bilirubin
(a) The molecular absorption coefficient of the labelled bilirubin in chloroform at 450 nm was between 56 OOO and 58 OOO.
(b) The absorption spectrum of the bilirubin in chloroform showed only a minor peak at 300 nm and a major one at 450 nm, indicating the absence of detectable amounts of biliverdin, which has major absorbance at 640 nm (With, 1968) .
(c) The pentdyopent reaction for dipyrroles was negative in an aqueous alkaline solution of the labelled bilirubin (With, 1968) .
(d) After partitioning of the labelled unconjugated bilirubin in the two-phase WeberSchalm solvent system (Weber & Schalm, 1962) 93% or more of the radioactivity was found in the lower non-polar phase. This behaviour is consistent with pure unconjugated bilirubin uncontaminated by the conjugated pigment and other polar compounds (Berk et al., 1969) .
The unconjugated [14C]bilirubin prepared in the above manner was sterile, pyrogen-free and had a specific radioactivity of 0 . 1 2 4 1 8 pcilpmol. It was dispensed in sterile vials under vacuum; each contained approximately 1 pCi of labelled bilirubin. The bilirubin was stored at -20°C in the dark until required.
Subjects
Seven normal subjects (five males and two females) ( Table 1 ) and eight patients with cirrhosis (five males and three females) ( Table  2) were studied. All the normal subjects with one exception (subject no. 4) were healthy members of the laboratory staff, and none gave a history of previous liver disease. Subject no. 4 had been extensively investigated for liver disease, but liver-function tests, liver histology, liver scan and radiological investigations of the biliary and gastrointestinal tract were normal. None of the normal male subjects was taking drugs at the time of the study, but the two female subjects had been taking oral contraceptives for over 2 years. Subject no. 6 was taking Norlestrin (Parke, Davis and Co.; 2.5 mg of norethisterone acetate and 0.1 mg of ethynyl oestradiol) and subject no. 7 Minovlar (Schering Chemical Co.; 1 mg of norethisterone acetate and 0.1 rng of ethynyl oestradiol). Liver biopsies had been performed in seven of the eight patients with cirrhosis; biopsy was not possible in patient no. 7 because of persistent thrombocytopenia. This patient had abnormal routine serum biochemistry (Table 2) , cutaneous stigmata of chronic liver disease, oesophageal varices and hypersplenism.
Patient no. 5 was thought to have alcoholic cirrhosis although liver biopsy did not show the classical changes of alcoholic liver disease (Scheuer, 1973) . Patients nos. 4,5 and 8 had had end-to-side portacaval anastomoses for bleeding oesophageal varices 8, 2 and 4 years previously respectively. At the time of study, these three patients were receiving lactulose and 50 g/day protein diets for mild portal-systemic encephalopathy. Patients no. 3 and no. 7 had evidence of oesophageal varices on bariumswallow examination. Patient no. 1, who had had ascites, had been treated with 22 mmol/day sodium diet and frusemide (40 mg/day) before the commencement of the present studies. The serum cholesterol concentration was normal in the patients in whom it was measured (patients nos. 1, 2, 4 and 5). None of the patients with cirrhosis was clinically jaundiced and none was itching. They were considered to be in a stable metabolic state with respect to body weight, packed cell volume and biochemical liverfunction tests.
The protocol for these studies had been approved by the Ethical Committee of the United Liverpool and Broadgreen Hospitals and, \:ith respect to radiation dosage, by the Medical Research Council. All studies were performed with the fully informed consent of each subject.
Protocol of the studies
Studies of unconjugated bilirubin metabolism.
The kinetics of unconjugated ['*C]bilirubin metabolism were investigated in all the above subjects by the following modifications of the methods of Berk et al. (1969) . (a) The unconjugated [ '*C]bilirubin was dissolved in 0.5 ml by sterile sodium hydroxide (100 mmol/l) and buffered with 10 ml hydroxide (100 mmol/l) and buffered with 10 rnl of sterile, pyrogen-free human albumin ( 
(1965).
Validation of extraction procedure. Serum bile acids are frequently elevated in patients with cirrhosis (Carey, 1973) and it is possible that they may alter the distribution of labelled unconjugated bilirubin in the Weber & Schalm solvent system. To investigate this possibility, the following experiment was performed. Three portions were taken of a plasma sample from a patient with Gilbert's syndrome who had a total bilirubin concentration of 41 pmolll. Nothing was added to the first portion and the bile salts sodium glycocholate, sodium taurocholate, sodium glycochenodeoxycholate and sodium taurochenodeoxycholate were added to the second so that their final concentrations were 5.94,2.23, 12.7 and 4.0 prnol/l respectively. The third portion contained the above bile salts at double the concentration of portion no. 2. The partitioning of the unlabelled unconjugated bilirubin in the three portions of plasma was then investigated in the Weber & Schalm system. The amount of bilirubin which passed into the upper polar layer of this system was 3.1, 4.0 and 3.4% for portions nos. 1, 2 and 3 respectively.
The experiment was repeated after addition of 3H-labelled unconjugated bilirubin to each portion. The amount of labelled bilirubin which now passed into the upper phase of the solvent system was 2.26, 2.31 and 2.34% of the total in portions nos. 1, 2 and 3 respectively. It has, therefore, been shown that concentrations of bile salts approximating those encountered in cirrhosis do not alter the partitioning of labelled bilirubin in the solvent system.
Studies by Owens (1975) have shown that the addition of increasing concentrations of conjugated bilirubin (method of Lucassen, 1961) to plasma increases the amount of this pigment which is distributed into the lower phase of the Weber & Schalm solvent system. However, in patients with slightly raised plasma conjugated bilirubin concentrations (up to 25 pmolll) only insignificant amounts of conjugated bilirubin enter the lower phase and accurate separation of the bile pigments is possible.
Estimation of erythrocyte volume. This was measured in patients nos. 1, 2, 3, 5, 6 and 7 by the SICr-labelled autologous erythrocyte method of Sterling & Gray (1950) as modified by Read (1954) . Total blood volume was calculated from the total erythrocyte volume, the peripheral venous packed cell volume (PCV) and the ratio whole-body packed cell volume/ venous packed cell volume of 0.91 in the following way.
Erythrocyte volume x 100
Venous PCV x 0.91 Total bloodvolume = The factor 0.91 compensates for the nonuniformity of the distribution of erythrocytes throughout the circulation (Mollison, 1967) . Plasma volumes were calculated as the differences between total blood and erythrocyte volume.
For the purpose of calculating erythrocyte lifespan from the bilirubin data, erythrocyte volume was taken to be 25 ml/kg body weight in the normal subjects and in patients no. 4 and no. 8 (Wasserman, Yoh & Rashkoff, 1951 (Matthews, 1957) . By the use of a 'hillclimbing technique' (Rosenbrock & Storey, 1966) these initial values were varied in a systematic manner until a minimal value for the sums of the squares of the differences between the fitted curve and the experimental data was obtained. To facilitate comparison between the data obtained in different studies, the computer-simulated curves of c.p.m./ml of plasma at zero time were normalized. That is, the sum of the exponential coefficients (gains) was set equal to 1.0. The number of radioactivity counts remaining in the plasma at the time t after injection were then expressed as a fraction of 1.0.
Having obtained values for the coefficients and rate constants of the threeexponentials model independent parameters of unconjugated [ I 4C]bilirubin metabolism were calculated by conventional methods (Donato, Matthews, Nosslin, Segre & Vitek, 1966; Berk et al., 1969) .
To gain further insight into the metabolism of unconjugated bilirubin the system was assumed to be compartmentalized as in the model proposed by Berk et al. (1969) (Fig. 1 (rapidly mixing pool-'plasma') and a single site of loss from a small rapidly exchanging pool 2 (liver'). The model-dependent parameters, pool sizes and fractional transfer rates are related to the exponential coefficients and rate constants of the fitted curve by the set of equations described by Skinner, Clark, Baker & Shipley (1959) . For this particular model configuration, two solutions are mathematically feasible resulting from the solution of a pair of quadratic equations. The solution leading to the set of values in which loss of bilirubin occurred from a small pool which exchanged rapidly with the plasma pool rather than from a large pool which exchanged slowly with the plasma was incorporated into the computer program.
The input rate of unconjugated bilirubin into pool 1 of the model (Fig. 1 ) was calculated as follows: if steady-state conditions apply the flux of bilirubin from pool 1 to pool 3 must equal the flux from pool 3 to pool 1. Moreover, the difference between the total flux of bilirubin into pool 1 and the total flux out of this pool must be equal to the input rate, which in turn is equal to the flux from pool 2 to the conjugated pool. So (Flz +F13) -(FZ1 +F31) = F2, = input rate in ,umol/min, where F12 = flux from pool 1 to pool 2, F13 = flux from pool 1 to pool 3, FZl = flux from pool 2 to pool l,FSl = flux from pool 3 to pool 1 and FZ0 = flux from pool 2 to conjugated pool.
The parameters of unconjugated [ "Clbilirubin metabolism in the normal subjects and patients with cirrhosis were compared by means of the unpaired Students' t-test.
Resalts
Explanations of terms used
Fractional clearance rate. The fraction of the rapidly mixing pool irreversibly cleared of bilirubin by the liver each minute.
Hepatic clearance rate. That part of the volume of distribution of bilirubin irreversibly cleared of pigment by the liver each minute.
Four hour retention. The amount of unwnjugated [ 14C]bilirubin remaining in the plasma at 4 h expressed as a percentage of the zero-time concentration obtained by extrapolation of the plasma disappearance curve to zero time.
Bilirubin production rate. The amount of bilirubin produced each day from the turnover of marrow, erythrocyte and hepatic haemoproteins.
Fractional transfer rate. The fraction of a pool transferred into another pool per minute.
Flux. The mass of bilirubin transferred from one pool to another each minute, calculated by multiplying the relevant fractional transfer rate by the mass of that pool.
Kinetics of unconjugated [ 14C]bilirubin metabolism
Normal subjects. The results in normal subjects are given in Tables 3 and 4 . Fig. 2 shows the 'average' plasma disappearance curve in these normal subjects. The normalized coefficients (gains) of the first, second and third exponentials were (mean f SD) 0.662 f 0.21 5, 0.259 f0.159 and 0.078 f0.081 respectively, and the rate constants for the corresponding exponentials were 0.031 +0.023,0.0062 f 0.0034 and 0.0014 f0.00099 min-' respectively.
Patients with cirrhosis. Tables 5 and 6 give the results for patients with cirrhosis. Fig. 2 shows the 'average' plasma disappearance curve of the labelled bilirubin in these patients. The normalized coefficients (gains) of the fist, second and third exponentials were (mean f SD) 0.447 f 0-134, 0.365 f0.130 and 0.188 f0.117 respectively, and mean rate constants of the corresponding exponentials were 0.0227 f 0.0092, 0.0014 k0.0052 and 0*0020 f0.0010 min-' respectively. The only one of these parameters that was significantly different from the corresponding value in the normal subjects was the smaller coefficient of the first exponential (P < 0.05).
Of the model-independent parameters of unconjugated [ '*C]bilirubin metabolism in the cirrhotic patients, the mean volume of distribution, the mean mass of the rapidly mixing pool and the mean 4 h retention were significantly greater than the corresponding values in the normal subjects (P<0.05, ~0 . 0 5 and ~0 . 0 1 respectively). In contrast, the mean fractional clearance rate and the mean estimated erythrocyte life-span were significantly less than the corresponding values in the normal subjects (P<O.O5). Mean hepatic clearance rate and mean bilirubin production rate were not significantly different from those in the normal subjects (P > 0.05).
Of the model-dependent parameters of unconjugated ['*C]bilirubin metabolism, the mean fractional transfer rates and fluxes from pool 1 to pool 3 and vice versa were significantly greater than the corresponding values in the normal subjects (P ~0 . 0 5 ) .
The mean fractional transfer rate from pool 1 to pool 2 was less than in the normal subjects and the mean fractional transfer rate from pool 2 to the conjugated pool was greater than in the normal subjects, but these differences were not statistically significant (P > 0.05).
Discussion
Unconjugated bilirubin metabolism in normal subjects
Berk et al. (1969) were the first to define the plasma disappearance curves of unconjugated ['*C]bilirubin in terms of three exponential functions. They showed that analysis of the curves in terms of three exponentials provided meaningful information not only about bilirubin metabolism but also about erythrocyte life-span. They proposed a simple model of bilirubin metabolism which was compatible with their experimental data. It was assumed that unconjugated bilirubin was contained in three communicating pools (Fig. 1) and that bilirubin in pool 1 (rapidly mixing pool-'plasma') exchanged with pools 2 ('hepatic') and 3 ('extravascular'), but that in pools 2 and 3 did not exchange with one another. It assumed also that the only input of unconjugated bilirubin was into pool 1 and that the only loss was from pool 2. The input into the system is due largely to catabolism of senescent erythrocytes and to ineffective erythropoiesis in the bone marrow, whereas output from the system is due largely to the conjugation of unconjugated bilirubin by the microsomesin the hepatocyte. The same authors showed that the model-independent parameters varied little between normal individuals or in the same normal individuals studied on different occasions. However, with the exception of the fractional transfer rate of bilirubin from pool 1 to pool 2, the model-dependent parameters of ['*C]bilirubin metabolism were not highly reproducible in the same individuals studied on different occasions, an observation that we have confirmed in one study (unpublished observations) . Tables 7 and 8 show the parameters of unconjugated ['4C]bilirubin metabolism in the normal subjects in the present study compared with the corresponding data published by Berk et al. (1969) . It can be seen that most are very similar in the two studies. However, the mean initial volume of distribution, the mean masses of pools 1 and 2 and the mean estimated erythrocyte life-span were greater in the present study, whereas the mean fractional 
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clearance rate, the mean hepatic clearance rate, the mean bilirubin production rate and fractional transfer rate of unconjugated bilirubin from pool 2 to the hepatic conjugated bilirubin were less. There are no obvious reasons for these discrepancies. In the study of Berk et al. (1969) values for the initial volume of distribution of labelled unconjugated bilirubin were similar to the plasma volumes measured with radio-iodinated albumin. Although there is a high affinity constant between albumin and unconjugated bilirubin (Jacobsen, 1969) , the kinetics of labelled albumin and labelled unconjugated bilirubin are different (Bloomer, Berk, Vegalla & Berlin, 1973) . It follows that there is no reason a priori why the initial volume of distribution of these two substances should be the same. In normal subjects no. 1 and no. 2, pool 2 is large since, although there is normal uptake by the liver in each case, the fractional loss rate (loss from pool 2 to pool 1 and the conjugated pool) is lower than for any of the other normal subjects. The statistical variability of the fluxes from pool 1 to pool 2, from pool 2 to pool 1 and from pool 2 to the conjugated pool was appreciably less than that of the other modeldependent parameters.
The fraction of the total amount of unconjugated bilirubin leaving the rapidly mixing pool per minute which enters the extravascular pool is given by the fraction J(A1 + I . , 2) (see Fig. 1 ). This fraction was 17.0% in the normal subjects. The mean sojourn of a bilirubin molecule in this extravascular pool calculated as 1/(&1 x 60) was 7.6 h in the present study. The mean ratio of the mass of unconjugated bilirubin in the extravascular extrahepatic pool to that in the intravascular pool (M3/M1) was 2.2, which is not appreciably different from the value of 2.7 obtained for this ratio by Berk et al. (1969) . As unconjugated bilirubin is transported tightly bound to albumin (Jacobsen, 1969) in the plasma and possibly in the extravascular pool it is pertinent to note that the mean sojourn time of an albumin molecule in the more rapidly exchanging of the two extravascular albumin pools has been estimated to be 9.6 h (Cohen, Freeman & McFarlane, 1961) and the ratio of the mass of extravascular albumin to intravascular albumin has been estimated to be in the range 1.0-1.5 (Dykes, 1968) .
In the present study, the kinetics of unconjugated [ ''C]bilirubin were not significantly different in the two women taking oral contraceptives from those in other normal subjects. Although these other subjects were male this does suggest that bilirubin metabolism is not grossly abnormal in women taking oral contraceptives who do not have overt side-effects. This inference contrasts with bromosulphthalein metabolism, which is usually abnormal in women taking oral contraceptives IArias, 1969).
Unconjugated bilirubin metabolism in cirrhosis
In previous studies of the kinetics of unconjugated [14C]bilirubin metabolism in patients with cirrhosis the plasma unconjugated bilirubin disappearance curves have been analysed in terms of two exponentials (Barrett et al., 1968; Schmidt ef al., 1971) and patients with appreciable conjugated hyperbilirubinae-mia have been studied (Schmidt et al., 1971; Bloomer et al., 1974) . Moreover, in the study of Schmidt el al. (1971) no attempt was made to separate the "C-labelled unconjugated bilirubin from the conjugated ['4C]bilirubin produced during the studies in order to define accurately the plasma disappearance curve of the unconjugated pigment. Schmidt et al. (1971) found that the mean half-times of both the first-and secondexponential components of the plasma disappearance curves of [14C]bilirubin were significantly greater in the cirrhotic patients than in the normal subjects. They therefore suggested that the rate of hepatic uptake of unconjugated bilirubin and its conjugation were decreased in cirrhotic patients, although multicompartmental analysis was not performed.
The volume of distribution of unconjugated ['4C]bilirubin was greater in the cirrhotic patients than in the normal subjects in the present study. This observation probably reflects, at least in part, the unexplained large plasma volume which is frequently found in cirrhosis (Lieberman & Reynolds, 1967) . Splenomegaly may contribute to this (Blendis, Ramboer & Williams, 1970) , but cannot be the entire explanation as some of the patients in the present study had had portacaval anastomoses and their spleens were of normal size. The reduced fractional clearance rate of bilirubin in the cirrhotic patients probably reflects the reduced fractional transfer rate from pool 1 to pool 2 ('hepatic uptake') as the fractional transfer rate from pool 2 to the conjugated pool ('conjugation') was somewhat increased. The reduced fractional transfer rate from pool 1 to pool 2 could be due to reduced liver blood flow, to damage to or reduction in the area of the plasma membrane of the hepatocytes, to reduced effective concentration of the cytoplasmic binding proteins (Levi, Gatmaitan & Arias, 1969) , or to a combination of all these factors.
In the cirrhotic patients, the mean flux of bilirubin from pool 1 to pool 2 was greater than normal, presumably reflecting in large measure the increased mass of the rapidly mixing pool. Despite a reduced fractional clearance rate of unconjugated [ '*C]bilirubin in the cirrhotic patients compared with normal, the absolute hepatic clearance rate was not reduced. The reason for this is that the reduced fractional clearance rate was associated with an increase in the volume of distribution of unconjugated bilirubin. A similar situation was found to exist with respect to the hepatic clearance of unlabelled human growth hormone in patients with chronic liver disease (Owens, Srivastava, Tompkins, Nabarro & Sonksen, 1973 ). It appears that the increased volume of distribution of these substances in liver disease enables hepatic clearance to be maintained, at least temporarily, in the presence of severe hepatic dysfunction.
The mean estimated erythrocyte life-span calculated from the turnover of unconjugated [ ' 'Clbilirubin was significantly less in the patients with cirrhosis than in the normal subjects. This is in agreement with the observations of Katz, Velasco, Guanan & Alezzandri (1964) , who found reduced erythrocyte life-span in patients with hepatobiliary disease by a 'Cr-labelled erythrocyte technique.
The slight elevation in fractional transfer rate of [''Clunconjugated bilirubin from pool 2 to the coqjugated bilirubin pool in the cirrhotic patients may well reflect a normal or slightly increased rate of conjugation of unconjugated bilirubin with glucuronic acid, a reaction catalysed by &he microsomal enzyme bilirubin uridine diphosphate glucuronyl transferase. Consistent with this possibility is the observation of Black & Billing (1969) that the activity of this enzyme was often increased in patients with cirrhosis.
The ratio of the mass of unconjugated bilirubin in pool 2 to that in pool 1 was less in the cirrhotic patients (0.68) than in the normal subjects (2.73), which suggests that the cirrhotic liver is less efficient at removing unconjugated bilirubin from the plasma against a concentration gradient. This inference is consistent with the reduced fractional transfer rate from pool 1 to pool 2.
The extravadarlintravascular pool ratio of unconjugated bilirubin was approximately 1.5 in the cirrhotic patients compared with 2 2 in the normal subjects. The corresponding value for albumin, found by Dykes (1968) in cirrhotic patients, was 1.32. This observation is consistent with the high attinity constant which uncoqiugated bilirubin has for albumin (Jacobsen, 1969) .
Cirrhotic patient no. 4 exhibited both a reduced erythrocyte lifespan and a large rapidly mixing pool. In the absence of a p preciably reduced fractional transfer rates, this must result in large values for the magnitudes of pools 2 and 3. In contrast, patient no. 5, although exhibiting a reduced erythrocyte lifespan, had a smaller value for pool 2 owing to the low value of the fractional transfer rate from pool 1 to pool 2.
In patient no. 1, who had a reduced erythrocyte life-span and a large rapidly mixing pool, the masses of both pools 2 and 3 were small because of the small fractional transfer rates from pool 1 to pool 2 and pool 1 to pool 3.
The data obtained in this study do not permit any conclusions to be drawn regarding the magnitude of the hepatic bilirubin synthesis in cirrhosis.
Models of unconjugated bilirubin metabolism
The main deficiency of the three-pool model of unconjugated [ 14C]bilirubin metabolism used in the present study is that it does not take into account the fact that some unconjugated bilirubin, produced from hepatic haem turnover, enters pool 2 directly (Berk et al., 1969; Jones, Bloomer & Berlin, 1971 ; Jones, Shrager, Bloomer, Berk, Howe & Berlin, 1972) . Such an additional input precludes an accurate solution of the model for pool masses and fractional transfer rates from the plasma disappearance curve of labelled unconjugated bilirubin without additional independent information. For example, if the rate of excretion of bilirubin in bile were known it would be possible to calculate all the parameters of a three-pool model that incorporates an input of unconjugated bilirubin directly into pool 2. It should be noted that a part of this input into pool 2 is conjugated and excreted into bile without prior passage through the plasma in the unconjugated form (Jones et al., 1971 (Jones et al., , 1972 and hence plasma bilirubin turnover underestimates total bilirubin production. However, it seems likely that the part of the direct input into pool 2 which does not appear as plasma unconjugated bilirubin is not large enough to result in appreciable errors in estimates of total bilirubin production from plasma bilirubin turnover, at least in normal subjects and patients with Gilbert's syndrome, haemolysis and acute intermittent porphyria. This prediction is supported by the finding of a close agreement between plasma bilirubin turnover and total bilirubin production derived from estimates of carbon monoxide excretion (Berk, Rodkey, Blaschke, Collison & Waggoner, 1974) . It is also supported by results of direct measurements of total bilirubin production, and the quantity of bilirubin synthesized in the liver which is conjugated and excreted into bile without prior passage through the plasma in the unconjugated form in patients with acute intermittent porphyria (Jones et al., 1971, 1972) . and the probability that hepatic metabolism of bilirubin in this disease is not appreciably different from normal (Bloomer, Berk, Bonkowsky, Stein, Berlin & Tschudy, 1971) . If these assumptions are correct plasma bilirubin turnover will underestimate total bilirubin production by less than 10%. Plasma bilirubin turnover may also be a satisfactory estimate of total bilirubin production in patients with cirrhosis provided that there is not a marked increase in hepatic haem turnover and hence in hepatic bilirubin production in this condition. At present there is no evidence which suggests that hepatic haem production is excessive in cirrhosis.
An input into pool 2 in the three-pool model of unconjugated bilirubin metabolism (Fig. 1) would not itself be expected to affect the transfer rates of the model. However, the calculated ratio of the mass of unconjugated bilirubin in the hepatic pool to that in the intravascular pool would be higher, the larger the direct input into the hepatic pool relative to that into the intravascular pool (Jones, Bloomer, Berk, Carson, Owens & Berlin, 1977) .
